We are live on ! Find out more
Raymond James Financial

Raymond James Financial Portfolio holdings

AUM $324B
1-Year Est. Return 22.36%
 

Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.

This Fund
S&P 500
This Quarter Est. Return
+2.4%
1 Year Est. Return
+22.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$321B
AUM Growth
+$10.3B
Cap. Flow
+$6.21B
Cap. Flow %
1.93%
Top 10 Hldgs %
22.69%
Holding
5,365
New
376
Increased
2,494
Reduced
2,121
Closed
209

Sector Composition

Rank Sector Weight
1 Technology 16.17%
2 Financials 8.91%
3 Industrials 6.61%
4 Healthcare 6.54%
5 Consumer Discretionary 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRAB icon
5026
CALL
Grab
GRAB
$15B
$30K ﹤0.01%
+10,000
New +$55.3K
MU icon
5027
PUT
Micron Technology
MU
$972B
$30K ﹤0.01%
+100
New +$22.9K
CIK
5028
Credit Suisse Asset Management Income Fund
CIK
$134M
$30K ﹤0.01%
+10,597
New +$30.2K
KULR icon
5029
KULR Technology Group
KULR
$127M
$29.9K ﹤0.01%
10,117
-3,450
-25% -$12.7K
DARE icon
5030
Dare Bioscience
DARE
$20.4M
$29.6K ﹤0.01%
15,334
CATX icon
5031
Perspective Therapeutics
CATX
$342M
$29.5K ﹤0.01%
+10,730
New +$30.6K
ONCY
5032
Oncolytics Biotech
ONCY
$95.8M
$29.2K ﹤0.01%
+33,368
New +$36.1K
ARBE icon
5033
Arbe Robotics
ARBE
$89.8M
$29.1K ﹤0.01%
+24,650
New +$40.7K
INO icon
5034
Inovio Pharmaceuticals
INO
$76.1M
$29K ﹤0.01%
16,688
+8
+0% +$18
CLIR icon
5035
ClearSign Technologies
CLIR
$26.5M
$28.8K ﹤0.01%
5,185
GLD icon
5036
CALL
SPDR Gold Trust
GLD
$143B
$28K ﹤0.01%
100
ZVIA icon
5037
Zevia
ZVIA
$108M
$27.8K ﹤0.01%
11,980
-1,988
-14% -$4.94K
ISRG icon
5038
CALL
Intuitive Surgical
ISRG
$139B
$27K ﹤0.01%
100
TOON icon
5039
Kartoon Studios
TOON
$35.3M
$27K ﹤0.01%
37,498
ZNTL icon
5040
Zentalis Pharmaceuticals
ZNTL
$297M
$26.9K ﹤0.01%
19,895
-700
-3% -$1.02K
SLV icon
5041
PUT
iShares Silver Trust
SLV
$32B
$26.5K ﹤0.01%
+500
New +$25K
SKYX icon
5042
SKYX Platforms
SKYX
$164M
$26K ﹤0.01%
12,000
NNDM
5043
Nano Dimension
NNDM
$343M
$25.9K ﹤0.01%
16,802
+2,756
+20% +$4.67K
NMG
5044
Nouveau Monde Graphite
NMG
$471M
$25.6K ﹤0.01%
+10,304
New +$30.2K
GEVO icon
5045
Gevo
GEVO
$382M
$25.3K ﹤0.01%
12,665
-3,350
-21% -$7.38K
LFT
5046
Lument Finance Trust
LFT
$35.9M
$24.9K ﹤0.01%
17,628
+92
+0.5% +$147
AGL icon
5047
Agilon Health
AGL
$1.63B
$24.8K ﹤0.01%
+1,440
New +$27.9K
SNDL icon
5048
Sundial Growers
SNDL
$318M
$24.1K ﹤0.01%
+14,526
New +$29.2K
MEDS
5049
DataMeds AI, Inc. Common Stock
MEDS
$4.56M
$23.3K ﹤0.01%
1,168
ANET icon
5050
CALL
Arista Networks
ANET
$242B
$22.5K ﹤0.01%
200

Similar funds

Raymond James Financial's Q4 2025 Portfolio in Review

As of Q4 2025, Raymond James Financial held 5,365 positions worth $321B, up 3.3% from $311B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James Financial's Q4 2025 filing shows 376 new, 2,494 increased, 2,121 reduced and 209 closed positions. Its largest new stake was Qnity Electronics Inc: 957,948 shares worth $78.2M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $186M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.

  • Raymond James Financial's largest Q4 2025 buy was Qnity Electronics Inc: 957,948 shares worth $78.2M.
  • Raymond James Financial added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $634M increase.
  • Raymond James Financial's biggest Q4 2025 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $186M.
  • Raymond James Financial fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $57.9M.
  • Raymond James Financial's ten largest holdings make up 23% of its $321B portfolio in Q4 2025.
  • Raymond James Financial opened 376 new positions and closed 209 in Q4 2025.
  • Raymond James Financial's portfolio value rose 3.3% quarter-over-quarter to $321B.

Based on Raymond James Financial's 13F filing for Q4 2025, filed 18 Feb 2026.